Expression levels of genes implicated in the working mechanism of lenalidomide predict treatment response in lower risk myelodysplastic syndrome patients

Lignende værker

• Challenging the status flow: how artificial intelligence is advancing diagnosis of myelodysplastic neoplasms
  af: Carolien Duetz, et al.
  Udgivet: (2023-04-01)
• Transcription factor 4 (<i>TCF4</i>) expression predicts clinical outcome in <i>RUNX1</i> mutated and translocated acute myeloid leukemia
  af: Florentien E.M. in't Hout, et al.
  Udgivet: (2020-06-01)
• High expression of transcription factor 4 (TCF4) is an independent adverse prognostic factor in acute myeloid leukemia that could guide treatment decisions
  af: Florentien E.M. in ’t Hout, et al.
  Udgivet: (2014-12-01)
• Divergent Autologous T Cell Responses to Leukaemic Dendritic Cells during Remission in Acute Promyelocytic Leukaemia
  af: Theresia M. Westers, et al.
  Udgivet: (2005-01-01)
• High levels of global hydroxymethylation predict worse overall survival in MDS patients treated with azacitidine
  af: Francesca Tiso, et al.
  Udgivet: (2025-01-01)